Loading...
Market
First organization to announce research grant in Manuel Elkin Patarroyo's name by end of 2025?
3
Manuel Elkin Patarroyo•Colombian•Bogotá•National University of Colombia•Ataco•Tolima•Patarroyo•World Health Organization•OMS•Robert Koch Prize•Fidic•Colombia
Resolution / Starting Odds
World Health Organization • 25%
National Institutes of Health • 25%
Colombian Government • 25%
Other • 25%
Official announcements from relevant organizations or media reports
Story
Manuel Elkin Patarroyo, Developer of First Synthetic Malaria Vaccine, Dies at 78 in Bogotá
Jan 9, 2025, 07:22 PM
Manuel Elkin Patarroyo, a renowned Colombian scientist known for his work on vaccines, passed away on January 9, 2025, at the age of 78 in Bogotá due to cardiorespiratory arrest. His death was confirmed by the National University of Colombia, where he served as a professor since 1972. Born in Ataco, Tolima, Patarroyo was celebrated for developing the first synthetic vaccine against malaria, known as SPf66, which he discovered in 1987. He donated this vaccine to the World Health Organization (OMS) for free distribution. Throughout his career, Patarroyo received numerous accolades, including the Prince of Asturias Award for Scientific and Technical Research in 1994 and the Robert Koch Prize in the same year. As the director of the Fundación Instituto de Inmunología de Colombia (Fidic), his contributions extended beyond the vaccine to mentoring a generation of researchers dedicated to advancing science in Colombia.
View original story
Similar markets
World Health Organization • 25%
Other • 25%
Centers for Disease Control and Prevention • 25%
European Medicines Agency • 25%
Oxford University • 25%
Harvard University • 25%
Other • 25%
Johns Hopkins University • 25%
American Medical Association • 25%
No Major Support • 25%
National Institutes of Health • 25%
Centers for Disease Control and Prevention • 25%
Other • 25%
Bill & Melinda Gates Foundation • 25%
World Health Organization (WHO) • 25%
National Institutes of Health (NIH) • 25%
No • 50%
Yes • 50%
Moderna • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
Yes • 50%
No • 50%
United Nations • 25%
Other • 25%
African Union • 25%
World Health Organization • 25%
African Union • 25%
WHO • 25%
United States CDC • 25%
Other • 25%
Bill & Melinda Gates Foundation • 25%
Other • 25%
World Health Organization (WHO) • 25%
The Carter Center • 25%
Moderna • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Other • 25%
National Science Foundation (NSF) • 25%
Defense Advanced Research Projects Agency (DARPA) • 25%
Google Research • 25%